PTH and hypertensive disorder: One major point of the bone protective effect of spironolactone could be its antimineralocorticoid effect, enabling enhanced tubular reabsorption of calcium resulting in higher serum calcium levels and a decrease in PTH, which would be in line with effects of thiazide diuretics which have been shown to be beneficial for bone health in the setting of hypertension [8, 46, 47].